BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33839639)

  • 1. Predictors of new-onset diabetic ketoacidosis in patients with moderate to severe COVID-19 receiving parenteral glucocorticoids: A prospective single-centre study among Indian type 2 diabetes patients.
    Mondal S; DasGupta R; Lodh M; Gorai R; Choudhury B; Hazra AK; Ganguly A
    Diabetes Metab Syndr; 2021; 15(3):795-801. PubMed ID: 33839639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-β+ KPD (ketosis-prone diabetes): A prospective study from Eastern India.
    Gupta RD; Atri A; Mondal S; Bhattacharjee A; Garai R; Hazra AK; Choudhury B; Dutta DS; Lodh M; Ganguly A
    J Diabetes Complications; 2022 Mar; 36(3):108100. PubMed ID: 34916147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study.
    Dżygało K; Nowaczyk J; Szwilling A; Kowalska A
    Pediatr Endocrinol Diabetes Metab; 2020; 26(4):167-175. PubMed ID: 33554490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic Ketoacidosis and Long-term Insulin Requirements in Youths with Newly Diagnosed Type 2 Diabetes During the SARS-CoV-2 Pandemic.
    Hao S; Cossen K; Westbrook AL; Umpierrez GE; Vellanki P
    Endocr Pract; 2023 Oct; 29(10):754-761. PubMed ID: 37451650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in the Number of Pediatric New-Onset Diabetes and Diabetic Ketoacidosis Cases During the COVID-19 Pandemic.
    Chambers MA; Mecham C; Arreola EV; Sinha M
    Endocr Pract; 2022 May; 28(5):479-485. PubMed ID: 35189332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic data.
    Dell'Aquila K; Lee J; Wang SH; Alamuri TT; Jennings R; Tang H; Mahesh S; Leong TJ; Fleysher R; Henninger EM; Veeraraghavan S; Mirhaji P; Hou W; Herold KC; Duong TQ
    Diabetes Obes Metab; 2023 Sep; 25(9):2482-2494. PubMed ID: 37254311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers.
    Ebekozien O; Agarwal S; Noor N; Albanese-O'Neill A; Wong JC; Seeherunvong T; Sanchez J; DeSalvo D; Lyons SK; Majidi S; Wood JR; Acharya R; Aleppo G; Sumpter KM; Cymbaluk A; Shah NA; Van Name M; Cruz-Aviles L; Alonso GT; Gallagher MP; Sanda S; Feuer AJ; Cossen K; Rioles N; Jones NY; Kamboj MK; Hirsch IB
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1755-e1762. PubMed ID: 33410917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Admissions for diabetic ketoacidosis in ethnic minority groups in a city hospital.
    Nyenwe E; Loganathan R; Blum S; Ezuteh D; Erani D; Palace M; Ogugua C
    Metabolism; 2007 Feb; 56(2):172-8. PubMed ID: 17224329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID-19.
    Field BCT; Ruan Y; Várnai KA; Davies J; Ryder REJ; Gandhi R; Harris S; Nagi D; Patel D; Kempegowda P; Wild SH; Wilmot EG; Khunti K; Rea R; Narendran P;
    Diabetes Obes Metab; 2023 Jul; 25(7):2012-2022. PubMed ID: 37016487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and insulin independence of Koreans with new-onset type 2 diabetes presenting with diabetic ketoacidosis.
    Seok H; Jung CH; Kim SW; Lee MJ; Lee WJ; Kim JH; Lee BW
    Diabetes Metab Res Rev; 2013 Sep; 29(6):507-13. PubMed ID: 23653323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and diabetic ketoacidosis: A case series at an urban district hospital in South Africa.
    Dicks HN; Naidoo K
    S Afr Fam Pract (2004); 2022 Sep; 64(1):e1-e5. PubMed ID: 36226949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597 children with diabetes.
    Elgenidy A; Awad AK; Saad K; Atef M; El-Leithy HH; Obiedallah AA; Hammad EM; Ahmad FA; Ali AM; Dailah HG; Elhoufey A; Taha SF
    Pediatr Res; 2023 Apr; 93(5):1149-1160. PubMed ID: 35953513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SARS-CoV-2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi-centre study of the first COVID-19 wave.
    McGlacken-Byrne SM; Drew SEV; Turner K; Peters C; Amin R
    Diabet Med; 2021 Sep; 38(9):e14640. PubMed ID: 34245598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period.
    Wu XY; She DM; Wang F; Guo G; Li R; Fang P; Li L; Zhou Y; Zhang KQ; Xue Y
    BMC Endocr Disord; 2020 Dec; 20(1):182. PubMed ID: 33317485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of biochemical parameters and diabetic ketoacidosis severity in adult patients with type 1 and type 2 diabetes.
    Charoenpiriya A; Chailurkit L; Ongphiphadhanakul B
    BMC Endocr Disord; 2022 Jan; 22(1):7. PubMed ID: 34986830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alarming increase in ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the first wave of the COVID-19 pandemic in Israel.
    Goldman S; Pinhas-Hamiel O; Weinberg A; Auerbach A; German A; Haim A; Zung A; Brener A; Strich D; Azoulay E; Levy-Khademi F; Ludar H; Koren I; Rachmiel M; Yackobovitch-Gavan M; Zuckerman-Levin N; David O; Halloun R; Cahn R; Ben-Ari T; Yeshayahu Y; Landau Z; Phillip M; Lebenthal Y
    Pediatr Diabetes; 2022 Feb; 23(1):10-18. PubMed ID: 34865288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and factors associated with diabetic ketoacidosis at diagnosis of type 1 diabetes: A report from a tertiary medical center in Central Pennsylvania.
    Bogale KT; Hale DE; Schaefer E; Bangalore Krishna K
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00186. PubMed ID: 33855199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Diabetic Ketoacidosis Among Pediatrics With Type 1 Diabetes Prior to and During COVID-19 Pandemic: A Meta-Analysis of Observational Studies.
    Alfayez OM; Aldmasi KS; Alruwais NH; Bin Awad NM; Al Yami MS; Almohammed OA; Almutairi AR
    Front Endocrinol (Lausanne); 2022; 13():856958. PubMed ID: 35355556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic Ketoacidosis Severity at Diagnosis and Glycaemic Control in the First Year of Childhood Onset Type 1 Diabetes-A Longitudinal Cohort Study.
    Khanolkar AR; Amin R; Taylor-Robinson D; Viner RM; Warner J; Gevers EF; Stephenson T
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory biomarkers predict higher risk of hyperglycemic crises but not outcomes in diabetic patients with COVID-19.
    Tao LC; Shu H; Wang Y; Hou Q; Li JJ; Huang XL; Hua F
    Front Endocrinol (Lausanne); 2024; 15():1287795. PubMed ID: 38455656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.